Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
13 mg [14C]-A4250 capsule----[3] 93, 297, 338
2A4250----[4] 93, 296, 297, 338
3A4250-015----[1] 297
4Chloride[1] Chloride ion---[29] 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338
5CRC (A3384)----[3] 93, 297, 338
6Eicosapentaenoic acid[1] Icosapent[1] D08061 --[6] 49, 96, 97, 296, 297, 338
7LUM001----[4] 93, 94, 297, 338
8LUM001 (Maralixibat)[1] Maralixibat[1] D10951 [2] SLC10A1,
SLC10A2 💬		[2] Bile secretion, Hepatitis B 💬[1] 297
9Magnesium[1] Magnesium---[19] 3, 6, 11, 13, 15, 46, 64, 70, 93, 97, 166, 225, 235, 256, 284, 291, 296, 297, 298
10Magnesium gluconate[1] Magnesium gluconate[1] D04835 --[2] 296, 297
11Magnesium sulfate[3] Magnesium gluconate,
Magnesium sulfate,
Sulfate ion		[2] D01108 ,
D04835 		--[3] 11, 296, 297
12Maralixibat[1] Maralixibat[1] D10951 [2] SLC10A1,
SLC10A2 💬		[2] Bile secretion, Hepatitis B 💬[3] 296, 297, 338
13Maralixibat (formely SHP625 or LUM001)[1] Maralixibat[1] D10951 [2] SLC10A1,
SLC10A2 💬		[2] Bile secretion, Hepatitis B 💬[3] 296, 297, 338
14MARALIXIBAT CHLORIDE[2] Chloride ion,
Maralixibat		[1] D10951 [2] SLC10A1,
SLC10A2 💬		[2] Bile secretion, Hepatitis B 💬[3] 296, 297, 338
15Odevixibat[1] Odevixibat[1] D11716 [1] SLC10A2 💬[1] Bile secretion 💬[3] 296, 297, 338
16PHENYLBUTYRATE[1] Phenylbutyric acid---[12] 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338
17Questran[1] Cholestyramine---[4] 93, 254, 297, 338
18Sulfate[1] Sulfate ion---[27] 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299